The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended new measures to reduce the risk of dosing errors with medicines containing methotrexate.
Adalimumab monotherapy and combination with methotrexate showed similar drug survival and PASI75 response rates in plaque psoriasis patients. Methotrexate reduced antidrug antibody levels but did not ...
New AI-enabled research tool, Cardiovascular Knowledge Graph (CardioKG), connects heart scans with genetics, boosting drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback